Log in to save to my catalogue

Immune checkpoints are predominantly co-expressed by clonally expanded CD4 + FoxP3 + intratumoral T-...

Immune checkpoints are predominantly co-expressed by clonally expanded CD4 + FoxP3 + intratumoral T-...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_52536a48956445e0b8dee1144f166f82

Immune checkpoints are predominantly co-expressed by clonally expanded CD4 + FoxP3 + intratumoral T-cells in primary human cancers

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

In addition to anti-PD(L)1, anti-CTLA-4 and anti-LAG-3, novel immune checkpoint proteins (ICP)-targeted antibodies have recently failed to demonstrate significant efficacy in clinical trials. In these trials, patients were enrolled without screening for drug target expression. Although these novel ICP-targeted antibodies were expected to stimulate...

Alternative Titles

Full title

Immune checkpoints are predominantly co-expressed by clonally expanded CD4 + FoxP3 + intratumoral T-cells in primary human cancers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_52536a48956445e0b8dee1144f166f82

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_52536a48956445e0b8dee1144f166f82

Other Identifiers

ISSN

1756-9966,0392-9078

E-ISSN

1756-9966

DOI

10.1186/s13046-023-02897-6

How to access this item